Related Articles
PIM1 kinase as a promise of targeted therapy in prostate cancer stem cells (Review)
<em>In vitro</em> assessment of the efficiency of the PIM‑1 kinase pharmacological inhibitor as a potential treatment for Burkitt's lymphoma
Downregulation of microRNA‑33a promotes cyclin‑dependent kinase 6, cyclin D1 and PIM1 expression and gastric cancer cell proliferation
PKD1 negatively regulates cell invasion, migration and proliferation ability of human osteosarcoma
PIM1 knockdown inhibits cell proliferation and invasion of mesothelioma cells